Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
AssigneePhico Therapeutics Ltd.
InventorHeather Marie Fairhead
Life of this patent
Estimating the term…
Abstract
A polypeptide having α/β type SASP activity, for use as a medicament.
Claims10
A composition for treating or inhibiting a bacterial infection comprising a polynucleotide encoding an α/β type small acid-soluble spore protein (SASP) in a bacteriophage delivery system which targets a bacterial cell.
A composition for inhibiting or preventing bacterial growth comprising a polynucleotide encoding an α/β type small acid-soluble spore protein (SASP) in a bacteriophage delivery system which targets a bacterial cell.
A composition for treating or inhibiting a bacterial infection comprising a polynucleotide encoding an α/β type small acid-soluble spore protein (SASP) in a bacteriophage which targets a bacterial cell, wherein the protein comprises the amino acid sequences kxexaxexg and gxvggxxxk, where x is any amino acid.
A composition for inhibiting bacterial cell growth comprising a polynucleotide encoding an α/β type small acid-soluble spore protein (SASP) in a bacteriophage which targets a bacterial cell, wherein the protein comprises the amino acid sequences kxexaxexg and gxvggxxxk, where x is any amino acid.
Dependencies are inferred from the claim text.